This inventor holds 2 USPTO granted patents. Top assignee: California Institute of Technology. Active years: 2001-2016.
Company Filing History:
Years Active: 2001-2016
Title: Martin E Budd: Innovator in DNA Research
Introduction
Martin E Budd is a prominent inventor based in Pasadena, CA. He has made significant contributions to the field of DNA research, holding a total of 2 patents. His work focuses on innovative solutions for genetic disorders and cancer treatment.
Latest Patents
One of his latest patents is titled "Inhibition of DNA2 in Fanconi anemia." This invention addresses the over-resection of DNA in Fanconi anemia (FA) cells, which stabilizes these cells and allows for safer cancer treatments in FA patients. The patent highlights the potential to decrease the lethality of FA cells and reduce bone marrow failure in affected individuals.
Another notable patent is related to "&bgr;-type DNA polymerases." This invention introduces novel DNA polymerases of the &bgr;-family, providing nucleic acids encoding these polymerases, as well as expression vectors and host cells. The methods for synthesizing nucleic acids using &bgr;-type DNA polymerases are also detailed in this patent.
Career Highlights
Martin E Budd is affiliated with the California Institute of Technology, where he continues to advance research in genetics and molecular biology. His work has garnered attention for its potential impact on treating genetic disorders and improving cancer therapies.
Collaborations
He has collaborated with notable colleagues, including Judith L Campbell and Kenneth Karanja, contributing to a dynamic research environment that fosters innovation.
Conclusion
Martin E Budd's contributions to DNA research exemplify the intersection of innovation and healthcare. His patents reflect a commitment to improving the lives of patients with genetic disorders and cancer.